AH Capital Management

a16z Capital Management as of March 31, 2026

Portfolio Holdings for a16z Capital Management

a16z Capital Management holds 16 positions in its portfolio as reported in the March 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Navan Cl A (NAVN) 28.9 $374M 28M 13.24
Figma Class A Com Stk (FIG) 26.2 $339M 16M 21.14
Meta Platforms Cl A (META) 9.4 $122M 213k 572.13
Revolution Medicines (RVMD) 6.9 $90M 921k 97.25
Nautilus Biotechnology (NAUT) 5.3 $69M 18M 3.88
Block Cl A (XYZ) 4.7 $61M 1.0M 60.18
Bioage Labs (BIOA) 4.4 $57M 3.2M 17.49
Maze Therapeatics (MAZE) 3.9 $51M 1.7M 29.85
Erasca (ERAS) 3.6 $46M 2.9M 16.18
Damora Therapeutics Com New (DMRA) 2.5 $32M 1.2M 25.90
Omada Health (OMDA) 2.2 $29M 2.3M 12.57
Camp4 Therapeutics Corp (CAMP) 0.7 $9.4M 2.1M 4.41
Aktis Oncology 0.6 $7.4M 415k 17.89
Bitgo Holdings Com Shs Cl A 0.4 $5.5M 666k 8.23
Ginkgo Bioworks Holdings Cl A New (DNA) 0.1 $666k 109k 6.13
Heritage Distilling Hldg (IPST) 0.0 $22k 83k 0.26